PROTECTION AGAINST MEASLES-VIRUS ENCEPHALITIS BY MONOCLONAL-ANTIBODIES BINDING TO A CYSTINE LOOP DOMAIN OF THE H PROTEIN MIMICKED BY PEPTIDES WHICH ARE NOT RECOGNIZED BY MATERNAL ANTIBODIES

Citation
D. Ziegler et al., PROTECTION AGAINST MEASLES-VIRUS ENCEPHALITIS BY MONOCLONAL-ANTIBODIES BINDING TO A CYSTINE LOOP DOMAIN OF THE H PROTEIN MIMICKED BY PEPTIDES WHICH ARE NOT RECOGNIZED BY MATERNAL ANTIBODIES, Journal of General Virology, 77, 1996, pp. 2479-2489
Citations number
54
Categorie Soggetti
Virology,"Biothechnology & Applied Migrobiology
Journal title
ISSN journal
00221317
Volume
77
Year of publication
1996
Part
10
Pages
2479 - 2489
Database
ISI
SICI code
0022-1317(1996)77:<2479:PAMEBM>2.0.ZU;2-G
Abstract
After immunization with measles virus (MV) several monoclonal antibodi es (MAbs) were obtained, which reacted with peptides corresponding to the amino acids 361-410 of the haemagglutinin protein (MV-H), Three of these MAbs (BH6, BH21 and BH216) inhibited haemagglutination, neutral ized MV in vitro and protected animals from a lethal challenge of rode nt-adapted neurotropic MV, These MAbs reacted with the 15-mer peptides H381 and H386 defining their overlapping region 386-395 as a sequenti al neutralizing and protective epitope, which can be imitated by a sho rt peptide, H381 and H386 share two Cys residues (C(386)KGKIQALC(394)E NPEWA) and for optimal MAb binding of peptide (or MV) disulphide bonds were required in addition to a linear C-terminal extension. Other MAb s bound to peptides C- (BH147, BH195) and N-terminally (BH168, BH171) adjacent to the loop but did not neutralize or protect, When sera from measles patients or from women of childbearing age were tested with t he peptides corresponding to this haemagglutinating and neutralizing e pitope (HNE), none of the sera recognized the 15-mer peptides of this region, while some reactivity was found to 30-mers homologous to diffe rent wild-type mutants, Its lack of recognition by maternal antibodies and its high degree of conservation would make the HNE loop an attrac tive candidate to include into a subunit vaccine, which could be admin istered during early childhood, independent of immune status.